These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 29356802)
21. Activity of Amphotericin B Formulations and Voriconazole, Alone or in Combination, against Biofilms of Vikelouda K; Simitsopoulou M; Skoura L; Antachopoulos C; Roilides E Antimicrob Agents Chemother; 2021 Oct; 65(11):e0063821. PubMed ID: 34370583 [No Abstract] [Full Text] [Related]
22. Susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitro. Martinez LR; Casadevall A Antimicrob Agents Chemother; 2006 Mar; 50(3):1021-33. PubMed ID: 16495265 [TBL] [Abstract][Full Text] [Related]
23. Inhibitory Effect of Sophorolipid on Candida albicans Biofilm Formation and Hyphal Growth. Haque F; Alfatah M; Ganesan K; Bhattacharyya MS Sci Rep; 2016 Mar; 6():23575. PubMed ID: 27030404 [TBL] [Abstract][Full Text] [Related]
24. In vitro antifungal and antibiofilm activities of auranofin against itraconazole-resistant Aspergillus fumigatus. Chen P; Yang J; Jin Y; Lu C; Feng Z; Gao F; Chen Y; Wang F; Shang Z; Lin W J Mycol Med; 2023 May; 33(2):101381. PubMed ID: 37037064 [TBL] [Abstract][Full Text] [Related]
25. Extracellular DNA release acts as an antifungal resistance mechanism in mature Aspergillus fumigatus biofilms. Rajendran R; Williams C; Lappin DF; Millington O; Martins M; Ramage G Eukaryot Cell; 2013 Mar; 12(3):420-9. PubMed ID: 23314962 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of conidiophore development in Aspergillus fumigatus by an Escherichia coli DH5α strain, a promising antifungal candidate against aspergillosis. Balhara M; Ruhil S; Kumar M; Dhankhar S; Chhillar AK J Mycol Med; 2014 Mar; 24(1):1-12. PubMed ID: 23978655 [TBL] [Abstract][Full Text] [Related]
28. Comparison of the in-vitro activity of voriconazole (UK-109,496), itraconazole and amphotericin B against clinical isolates of Aspergillus fumigatus. Cuenca-Estrella M; Rodríguez-Tudela JL; Mellado E; Martínez-Suárez JV; Monzón A J Antimicrob Chemother; 1998 Oct; 42(4):531-3. PubMed ID: 9818755 [TBL] [Abstract][Full Text] [Related]
29. Aspergillus fumigatus forms biofilms with reduced antifungal drug susceptibility on bronchial epithelial cells. Seidler MJ; Salvenmoser S; Müller FM Antimicrob Agents Chemother; 2008 Nov; 52(11):4130-6. PubMed ID: 18710910 [TBL] [Abstract][Full Text] [Related]
30. Effects of Itraconazole and Micafungin on Aspergillus fumigatus Biofilms. Liu M; Zheng H; Zeng R; Liang G; Zheng N; Liu W Mycopathologia; 2021 Jun; 186(3):387-397. PubMed ID: 33956291 [TBL] [Abstract][Full Text] [Related]
31. First determination of azole resistance in Aspergillus fumigatus strains carrying the TR34/L98H mutations in Turkey. Özmerdiven GE; Ak S; Ener B; Ağca H; Cilo BD; Tunca B; Akalın H J Infect Chemother; 2015 Aug; 21(8):581-6. PubMed ID: 26048062 [TBL] [Abstract][Full Text] [Related]
32. A comparative study of the in vitro susceptibilities of clinical and laboratory-selected resistant isolates of Aspergillus spp. to amphotericin B, itraconazole, voriconazole and posaconazole (SCH 56592). Manavathu EK; Cutright JL; Loebenberg D; Chandrasekar PH J Antimicrob Chemother; 2000 Aug; 46(2):229-34. PubMed ID: 10933645 [TBL] [Abstract][Full Text] [Related]
33. In vitro antifungal activities of amphotericin B in combination with acteoside, a phenylethanoid glycoside from Colebrookea oppositifolia. Ali I; Sharma P; Suri KA; Satti NK; Dutt P; Afrin F; Khan IA J Med Microbiol; 2011 Sep; 60(Pt 9):1326-1336. PubMed ID: 21474610 [TBL] [Abstract][Full Text] [Related]
34. Antifungal effect of triclosan on Aspergillus fumigatus: quorum quenching role as a single agent and synergy with liposomal amphotericin-B. Tamimi R; Kyazze G; Keshavarz T World J Microbiol Biotechnol; 2022 Jun; 38(8):142. PubMed ID: 35718814 [TBL] [Abstract][Full Text] [Related]
35. Scanning Quadrupole Data-Independent Acquisition, Part B: Application to the Analysis of the Calcineurin-Interacting Proteins during Treatment of Aspergillus fumigatus with Azole and Echinocandin Antifungal Drugs. Juvvadi PR; Moseley MA; Hughes CJ; Soderblom EJ; Lennon S; Perkins SR; Thompson JW; Geromanos SJ; Wildgoose J; Richardson K; Langridge JI; Vissers JPC; Steinbach WJ J Proteome Res; 2018 Feb; 17(2):780-793. PubMed ID: 29251506 [TBL] [Abstract][Full Text] [Related]
36. The Influence of Genetic Stability on Dos Reis TF; Silva LP; de Castro PA; Almeida de Lima PB; do Carmo RA; Marini MM; da Silveira JF; Ferreira BH; Rodrigues F; Malavazi I; Goldman GH G3 (Bethesda); 2018 Jan; 8(1):265-278. PubMed ID: 29150592 [TBL] [Abstract][Full Text] [Related]
37. Development and antimicrobial susceptibility studies of in vitro monomicrobial and polymicrobial biofilm models with Aspergillus fumigatus and Pseudomonas aeruginosa. Manavathu EK; Vager DL; Vazquez JA BMC Microbiol; 2014 Mar; 14():53. PubMed ID: 24588809 [TBL] [Abstract][Full Text] [Related]
38. In vitro interactions of antifungal agents and tacrolimus against Aspergillus biofilms. Gao L; Sun Y Antimicrob Agents Chemother; 2015 Nov; 59(11):7097-9. PubMed ID: 26303797 [TBL] [Abstract][Full Text] [Related]
39. Disruption of Aspergillus fumigatus biofilm by Streptococcus pneumoniae: Mycelial fragmentation by hydrogen peroxide. Iwahashi J; Kamei K; Watanabe H J Infect Chemother; 2020 Aug; 26(8):831-837. PubMed ID: 32414689 [TBL] [Abstract][Full Text] [Related]
40. Analysis and description of the stages of Aspergillus fumigatus biofilm formation using scanning electron microscopy. González-Ramírez AI; Ramírez-Granillo A; Medina-Canales MG; Rodríguez-Tovar AV; Martínez-Rivera MA BMC Microbiol; 2016 Oct; 16(1):243. PubMed ID: 27756222 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]